Iqbal, A. et al. 2022. Benefits of six week and personalized dosing of pembrolizumab considering ongoing delta variant surge. Journal of the Pakistan Medical Association. 72, 3 (Feb. 2022). DOI:https://doi.org/10.47391/JPMA.4660.